Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040542 | SCV000064233 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | c.61708+10G>C in Intron 273 of TTN: This variant is not expected to have clinica l significance because it is not located within the splice consensus sequence an d has been identified in 0.5% (17/3094) of African American chromosomes from a b road population by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS; dbSNP rs72646883). |
Eurofins Ntd Llc |
RCV000040542 | SCV000228499 | likely benign | not specified | 2014-09-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000040542 | SCV000236677 | benign | not specified | 2014-07-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000228229 | SCV000286799 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-02 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769961 | SCV000901387 | benign | Cardiomyopathy | 2016-08-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839681 | SCV002100319 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839682 | SCV002100320 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839683 | SCV002100321 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839680 | SCV002100322 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040542 | SCV004038596 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541170 | SCV004759409 | likely benign | TTN-related disorder | 2019-12-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |